
3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Indicator Signals
2026-09-01 08:02:283B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has recently experienced a notable shift in its technical momentum, moving from a mildly bullish stance to a more sideways trend. Despite a modest day gain of 0.51%, the stock’s technical indicators present a complex picture, with mixed signals across weekly and monthly timeframes. This article analyses the latest technical parameters, price momentum, and relative performance against the broader market to provide investors with a comprehensive view.
Read full news article
3B Blackbio DX Ltd Upgraded to Hold as Technicals Improve and Financials Show Resilience
2026-08-31 08:08:423B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has seen its investment rating upgraded from Sell to Hold as of 28 August 2026. This change reflects a nuanced improvement across technical indicators, financial performance, valuation metrics, and overall quality assessment, signalling a cautiously optimistic outlook for investors.
Read full news article
3B Blackbio DX Ltd Shows Technical Momentum Shift Amid Mixed Indicator Signals
2026-08-31 08:01:013B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has witnessed a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, moving averages, and volume-based metrics, reflecting a nuanced outlook for investors as the stock trades at ₹1,438.75, up 6.20% on 31 Aug 2026.
Read full news article
3B Blackbio DX Ltd Technical Momentum Shifts Amid Mixed Market Signals
2026-08-27 08:01:303B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a sideways trend. Despite a recent upgrade in price action, the stock’s technical indicators present a complex picture, reflecting both bullish and bearish signals across different time frames. This article analyses the latest technical parameters, price momentum, and relative performance against the Sensex to provide a comprehensive view for investors.
Read full news article
3B Blackbio DX Ltd is Rated Sell
2026-08-25 10:10:493B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics presented here reflect the stock's current position as of 25 August 2026, providing investors with an up-to-date view of its fundamentals, valuation, financial trends, and technical outlook.
Read full news article
3B Blackbio DX Ltd Technical Momentum Shifts Amid Bearish Sentiment
2026-08-21 08:01:023B Blackbio DX Ltd, a micro-cap player in the Healthcare Services sector, has experienced a notable shift in its technical momentum, reflecting a complex interplay of bearish and mildly bullish signals. Despite a recent downgrade from Hold to Sell by MarketsMOJO, the stock’s technical indicators reveal nuanced trends that investors should carefully consider amid ongoing market volatility.
Read full news article
3B Blackbio DX Ltd Faces Bearish Momentum Amid Technical Downgrade
2026-08-19 08:01:483B Blackbio DX Ltd, a micro-cap player in the healthcare services sector, has experienced a notable shift in its technical momentum, moving from a mildly bearish stance to a more pronounced bearish trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, Bollinger Bands, and moving averages, reflecting growing investor caution amid recent price declines and underperformance relative to broader market benchmarks.
Read full news article
3B Blackbio DX Ltd is Rated Sell
2026-08-14 10:10:593B Blackbio DX Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 23 March 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 August 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
29-Aug-2026 | Source : BSEAnalyst/Investor Meet Outcome
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
25-Aug-2026 | Source : BSEAnalyst/ Investor Meet Intimation
Announcement under Regulation 30 (LODR)-Newspaper Publication
14-Aug-2026 | Source : BSENewspaper Publication of Unaudited Financial Results for the quarter ended 30th June 2026
Corporate Actions
No Upcoming Board Meetings
3B Blackbio DX Ltd has declared 40% dividend, ex-date: 19 Sep 25
No Splits history available
No Bonus history available
No Rights history available






